303 related articles for article (PubMed ID: 36992139)
1. Post-COVID-19 Fungal Infection in the Aged Population.
Chavda VP; Mishra T; Kamaraj S; Punetha S; Sengupta O; Joshi Y; Vuppu S; Vaghela D; Vora L
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992139
[TBL] [Abstract][Full Text] [Related]
2. Fungal pathogens and COVID-19.
Singh A; Kaur A; Chowdhary A
Curr Opin Microbiol; 2023 Oct; 75():102365. PubMed ID: 37625261
[TBL] [Abstract][Full Text] [Related]
3. The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.
Akhtar N; Khurshid Wani A; Kant Tripathi S; Prakash A; Amin-Ul Mannan M
Curr Res Biotechnol; 2022; 4():337-349. PubMed ID: 35942223
[TBL] [Abstract][Full Text] [Related]
4. Root Causes of Fungal Coinfections in COVID-19 Infected Patients.
Amin A; Vartanian A; Poladian N; Voloshko A; Yegiazaryan A; Al-Kassir AL; Venketaraman V
Infect Dis Rep; 2021 Dec; 13(4):1018-1035. PubMed ID: 34940403
[TBL] [Abstract][Full Text] [Related]
5. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.
Bhatt K; Agolli A; Patel MH; Garimella R; Devi M; Garcia E; Amin H; Domingue C; Guerra Del Castillo R; Sanchez-Gonzalez M
Discoveries (Craiova); 2021 Mar; 9(1):e126. PubMed ID: 34036149
[TBL] [Abstract][Full Text] [Related]
6. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
7. Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article.
Zia M; Goli M
J Int Med Res; 2021 Sep; 49(9):3000605211043413. PubMed ID: 34494475
[TBL] [Abstract][Full Text] [Related]
8. Overview of COVID-19-Associated Invasive Fungal Infection.
Shishido AA; Mathew M; Baddley JW
Curr Fungal Infect Rep; 2022; 16(3):87-97. PubMed ID: 35846240
[TBL] [Abstract][Full Text] [Related]
9. A systematic review on SARS-CoV-2-associated fungal coinfections.
Soni S; Namdeo Pudake R; Jain U; Chauhan N
J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
[TBL] [Abstract][Full Text] [Related]
10. Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; Ruiz-Gaitán A; García-Vidal C; Salavert M; Ramírez P; Puchades F; García-Hita M; Alastruey-Izquierdo A; Quindós G
Rev Iberoam Micol; 2020; 37(2):41-46. PubMed ID: 33041191
[TBL] [Abstract][Full Text] [Related]
11. An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?
Vitale RG; Afeltra J; Seyedmousavi S; Giudicessi SL; Romero SM
Braz J Microbiol; 2022 Jun; 53(2):759-775. PubMed ID: 35315001
[TBL] [Abstract][Full Text] [Related]
12. Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients.
Baten N; Wajed S; Talukder A; Masum MHU; Rahman MM
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):64. PubMed ID: 35529527
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Plethora of Fungal Infections.
Kundu R; Singla N
Curr Fungal Infect Rep; 2022; 16(2):47-54. PubMed ID: 35432691
[TBL] [Abstract][Full Text] [Related]
14. When to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection.
Pruthi HS
Curr Clin Microbiol Rep; 2022; 9(4):60-68. PubMed ID: 36345368
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019-Associated Invasive Fungal Infection.
Baddley JW; Thompson GR; Chen SC; White PL; Johnson MD; Nguyen MH; Schwartz IS; Spec A; Ostrosky-Zeichner L; Jackson BR; Patterson TF; Pappas PG
Open Forum Infect Dis; 2021 Dec; 8(12):ofab510. PubMed ID: 34877364
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of opportunistic fungal lung co-infections in COVID-19: What the radiologist needs to know.
Nair AV; Ramanathan S; Sanghavi P; Manchikanti V; Satheesh S; Al-Heidous M; Jajodia A; Macdonald DB
Radiologia (Engl Ed); 2022; 64(6):533-541. PubMed ID: 36402539
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated opportunistic infections: a snapshot on the current reports.
Abdoli A; Falahi S; Kenarkoohi A
Clin Exp Med; 2022 Aug; 22(3):327-346. PubMed ID: 34424451
[TBL] [Abstract][Full Text] [Related]
18. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
[TBL] [Abstract][Full Text] [Related]
19. Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes.
Chiurlo M; Mastrangelo A; Ripa M; Scarpellini P
New Microbiol; 2021 Apr; 44(2):71-83. PubMed ID: 34240742
[TBL] [Abstract][Full Text] [Related]
20. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
